≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Morphin

Endpoint Browser

RX_MORPHIN

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC — N02AA01|N02AG01|N02AA51

1 out of 7 registries used, show all original rules.

631

4. Check minimum number of events

Min. number of events 3
631

5. Include endpoints

None

631

6. Filter based on genotype QC (FinnGen only)

631

Control definitions (FinnGen only)

Control exclude
RX_OPIOIDS

Extra metadata

First used in FinnGen datafreeze
DF4

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 631 242 389
Unadjusted period prevalence (%) 0.14 0.08 0.17
Median age at first event (years) 69.57 67.57 70.82

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
491
Matched controls
4909
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N02AA01
ATC
morphine; systemic, rectal
+∞
323.0
491
6
N02AA05
ATC
oxycodone; systemic
41.5
216.4
282
154
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
41.8
139.0
175
64
A03FA01
ATC
metoclopramide; systemic, rectal
11.6
116.9
262
440
130
Kela drug reimbursment
Malignant tumour
19.0
114.2
186
152
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
79.8
109.1
121
20
Z51.5
ICD-10 Finland
Palliative care
22.3
106.9
162
106
N02AX02
ATC
tramadol; systemic, rectal
7.9
94.0
290
755
A06AD11
ATC
lactulose; oral
6.5
61.7
191
437
N03AX16
ATC
pregabalin; oral
7.2
59.9
166
324
H02AB02
ATC
dexamethasone; systemic
8.3
54.0
131
206
N02AC04
ATC
dextropropoxyphene; oral
17.9
49.6
79
52
A06AH03
ATC
naloxegol; oral
515.3
48.2
47
*
N06AA09
ATC
amitriptyline; systemic
8.4
44.9
106
156
N03AX12
ATC
gabapentin; oral
7.0
41.5
112
200
N05AD01
ATC
haloperidol; systemic
12.1
41.0
77
74
H02AB06
ATC
prednisolone; systemic
3.5
37.3
285
1398
N06AX21
ATC
duloxetine; oral
8.4
36.4
84
117
A04AA01
ATC
ondansetron; systemic, rectal
9.8
32.7
68
79
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
14.2
32.5
56
44
A04AA02
ATC
granisetron; systemic, transdermal
9.4
30.9
66
80
N05BA04
ATC
oxazepam; oral
3.6
30.2
165
598
WF049
NOMESCO Finland
Radiotherapy of metastasis
13.1
28.7
51
43
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
6.3
28.6
81
150
C03CA01
ATC
furosemide; systemic
2.9
26.7
238
1201
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.8
26.5
127
408
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
26.1
185
801
N02AA03
ATC
hydromorphone; systemic, rectal
274.1
25.9
26
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.4
25.9
83
178
JN4BD
NOMESCO Finland
Extensive body CT
4.7
25.9
96
242
N05CF01
ATC
zopiclone; oral
2.9
25.8
210
995
N06AX11
ATC
mirtazapine; oral
3.1
25.8
180
768
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
24.5
197
918
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.8
23.6
85
207
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.4
23.5
53
70
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.9
23.0
50
62
N02AJ06
ATC
codeine and paracetamol; systemic
3.3
21.9
128
474
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
12.0
21.8
40
36
N07BC02
ATC
methadone; systemic
229.7
21.8
22
*
J96.1
ICD-10 Finland
Chronic respiratory failure
9.4
21.6
45
52
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
27.9
21.6
29
11
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
21.3
233
1277
N05CD07
ATC
temazepam; oral
3.4
21.1
114
396
J01MA12
ATC
levofloxacin; systemic
3.2
20.9
129
493
R06.0
ICD-10 Finland
Dyspnoea
2.9
20.6
152
657
M01AE03
ATC
ketoprofen; systemic, rectal
2.6
20.4
210
1102
N06AX16
ATC
venlafaxine; oral
4.6
20.2
74
182
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
4.8
20.1
71
168
R03BB04
ATC
tiotropium bromide; inhalant
3.5
19.4
98
322
ZX070
NOMESCO Finland
Intensity modified radiotherapy
13.0
19.4
34
28
SPAT1109
SPAT
Analgesia with portable analgesic pump
72.8
18.8
21
*
N05BA01
ATC
diazepam; systemic, rectal
3.6
18.8
94
306
L01CA04
ATC
vinorelbine; systemic
40.1
18.7
23
6
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
40.1
18.7
23
6
A07AA02
ATC
nystatin; oral
5.8
18.5
54
103
A02BC01
ATC
omeprazole; systemic
2.6
18.3
171
840
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.1
18.2
75
206
N05AA02
ATC
levomepromazine; systemic
7.1
18.1
45
69
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.6
18.0
161
770
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.8
18.0
52
98
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
17.7
87
278
N05BA06
ATC
lorazepam; systemic, sublingual
5.4
17.6
54
109
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.1
17.6
109
414
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.5
17.5
87
281
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
4.9
17.5
59
133
N03AX09
ATC
lamotrigine; oral
9.8
17.4
35
38
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
6.2
17.3
47
82
M05BA02
ATC
clodronic acid; systemic
32.8
17.2
22
7
N03AE01
ATC
clonazepam; systemic
5.9
17.0
48
88
TGD00
NOMESCO Finland
Needle biopsy of lung
36.4
16.8
21
6
R52.1
ICD-10 Finland
Chronic intractable pain
93.2
16.7
18
*
B01AB10
ATC
tinzaparin; parenteral
4.8
16.5
56
127
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
41.6
16.4
20
5
R52.2
ICD-10 Finland
Other chronic pain
10.9
16.4
31
30
JN4AD
NOMESCO Finland
Body CT examination
4.1
16.2
65
174
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.2
15.9
50
104
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.9
15.9
105
415
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
10.6
15.7
30
30
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.7
15.5
45
85
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
16.7
15.4
24
15
SPAT1229
SPAT
Assessment of need for aid
4.1
15.1
61
164
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
5.7
14.9
43
81
R28
ICPC
Limited function/disability (R)
17.1
14.9
23
14
348
Kela drug reimbursment
Roflumilast
82.6
14.6
16
*
R03AC02
ATC
salbutamol; inhalant
2.2
14.6
236
1476
L01XX11
ATC
estramustine; systemic
37.2
14.5
18
5
A01
ICPC
Pain general/multiple sites
4.7
14.4
50
116
WF004
NOMESCO Finland
Palliative radiotherapy
13.9
14.3
24
18
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
23.1
14.3
20
9
SPAT1255
SPAT
Intravenous administration of medicine
4.6
14.3
50
117
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
14.1
180
1008
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
8.6
14.0
30
37
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
5.2
13.8
43
89
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
7.4
13.6
32
46
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
13.5
123
580
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
13.5
113
509
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
14.3
13.4
22
16
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
14.3
13.4
22
16
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
13.3
209
1276
GD1AD
NOMESCO Finland
Thorax CT examination
5.6
12.8
37
70
SPAT1254
SPAT
Administration of medicine
2.8
12.8
91
373
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
12.8
68
230
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.5
12.7
113
525
R50.9
ICD-10 Finland
Fever, unspecified
2.9
12.6
83
323
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
8.0
12.6
28
37
WX721
NOMESCO Finland
Oxygen concentrator therapy
+∞
12.5
12
*
WX725
NOMESCO Finland
Noninvasive ventilation
5.6
12.5
36
68
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.7
12.4
28
38
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.6
12.3
43
101
A02BC02
ATC
pantoprazole; systemic
2.0
12.3
288
2039
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.1
12.0
38
80
N07BA03
ATC
varenicline; oral
6.8
11.7
29
45
R84
ICPC
Malignant neoplasm bronchus/lung
66.5
11.7
13
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
14.1
11.5
19
14
N06AB10
ATC
escitalopram; oral
2.7
11.4
84
351
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
35.9
11.3
14
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
25.7
11.2
15
6
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
11.5
11.1
20
18
WZC30
NOMESCO Finland
Teaching
3.0
11.1
68
253
SPAT1245
SPAT
Provision of support and information to patient’s family members
4.0
11.1
44
117
ZX080
NOMESCO Finland
Image guided radiotherapy
10.4
11.1
21
21
N05BA12
ATC
alprazolam; oral
3.3
10.9
57
190
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
8.6
10.9
23
28
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.4
10.9
39
94
N05AH04
ATC
quetiapine; oral
2.7
10.9
78
320
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
15.9
10.9
17
11
N06AB04
ATC
citalopram; systemic
2.3
10.9
109
533
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
10.9
10.9
20
19
B01AB05
ATC
enoxaparin; parenteral
2.1
10.8
137
749
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
6.6
10.8
27
43
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
5.7
10.7
30
55
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.0
10.7
29
51
T36
ICD-10 Finland
Poisoning by systemic antibiotics
8.3
10.7
23
29
ABD99
NOMESCO Finland
Other operation on spinal cord or nerve for pain or impaired function
61.3
10.7
12
*
R03DX07
ATC
roflumilast; oral
61.3
10.7
12
*
N06AX03
ATC
mianserin; oral
4.7
10.7
36
82
M54.1
ICD-10 Finland
Radiculopathy
6.6
10.5
26
41
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
+∞
10.4
10
*
J94.8
ICD-10 Finland
Other specified pleural conditions
8.5
10.4
22
27
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.5
10.4
90
407
M01AX17
ATC
nimesulide; oral
2.2
10.4
122
643
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
7.4
10.4
24
34
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.5
10.4
90
409
M01AH02
ATC
rofecoxib; oral
2.7
10.3
71
285
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
4.7
10.3
34
76
N06AX12
ATC
bupropion; oral
6.1
10.3
27
46
M01AH01
ATC
celecoxib; oral (coxibs)
2.5
10.1
86
385
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
11.6
10.1
18
16
A04AD12
ATC
aprepitant; systemic
11.6
10.1
18
16
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
9.4
10.1
20
22
1850A
ICD-9 Finland
Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]
12.5
9.9
17
14
R02
ICPC
Shortness of breath/dyspnoea
2.9
9.9
64
245
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.4
9.9
35
84
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.6
9.8
33
75
R95
ICPC
Chron obstructive pulmonary disease
5.8
9.8
27
49
A01AB09
ATC
miconazole; local oral
3.0
9.8
56
199
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
9.7
142
819
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
9.7
104
524
JDB10
NOMESCO Finland
Percutaneous gastrostomy
13.7
9.7
16
12
SPAT1262
SPAT
Handing over of treatment supplies
2.2
9.6
104
528
M01AE51
ATC
ibuprofen, combinations; systemic
11.7
9.6
17
15
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
30.7
9.4
12
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
9.3
76
332
ZXD05
NOMESCO Finland
Urgent procedure
2.0
9.3
147
872
M03BC01
ATC
orphenadrine (citrate); systemic
2.5
9.3
79
356
A02BX02
ATC
sucralfate; oral
4.0
9.2
36
95
A02BA02
ATC
ranitidine; systemic
2.1
9.2
112
597
M05BX04
ATC
denosumab; parenteral
4.4
9.2
32
76
ZXE00
NOMESCO Finland
One hour or less
1.9
9.2
178
1137
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
9.1
92
450
M54.4
ICD-10 Finland
Lumbago with sciatica
2.9
9.1
57
215
N06AA12
ATC
doxepin; systemic
4.0
9.0
35
92
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
5.7
9.0
25
46
XG466
NOMESCO Finland
Sleep oxymetry
5.1
8.9
27
55
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
24.5
8.9
12
5
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.3
8.9
32
78
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
5.3
8.9
26
51
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
8.8
8.9
18
21
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
8.8
76
343
M48.0
ICD-10 Finland
Spinal stenosis
2.9
8.8
54
199
L28
ICPC
Limited function/disability (L)
2.3
8.8
88
429
M01AE02
ATC
naproxen; oral, rectal
1.8
8.8
218
1507
L01BC06
ATC
capecitabine; oral
5.2
8.8
26
52
M54.3
ICD-10 Finland
Sciatica
4.8
8.7
28
61
TAC99
NOMESCO Finland
Other blockade for chronic pain
14.4
8.7
14
10
A46
ICD-10 Finland
Erysipelas
2.5
8.7
72
318
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
16.6
8.6
13
8
R60.0
ICD-10 Finland
Localized oedema
2.7
8.6
58
230
N03AF02
ATC
oxcarbazepine; oral
4.9
8.6
27
58
J01MA14
ATC
moxifloxacin; systemic
3.0
8.5
49
175
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
28.0
8.5
11
*
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
8.5
81
386
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
91.5
8.4
9
*
S97
ICPC
Chronic ulcer skin
3.8
8.4
34
93
M54.5
ICD-10 Finland
Low back pain
2.0
8.3
114
637
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
7.3
8.3
19
27
A41.9
ICD-10 Finland
Sepsis, unspecified
4.2
8.3
30
74
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.3
8.3
41
132
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
8.3
80
383
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
5.0
8.2
25
52
J01FF01
ATC
clindamycin; systemic
2.0
8.2
119
678
A02BC05
ATC
esomeprazole; systemic
1.8
8.1
166
1070
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
17.5
8.1
12
7
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.5
8.1
27
62
R03AK07
ATC
formoterol and budesonide; inhalant
2.3
8.0
80
387
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.0
8.0
31
82
JN4CD
NOMESCO Finland
Very extensive body CT
4.1
8.0
30
77
M01AB55
ATC
diclofenac, combinations; oral
3.1
8.0
42
142
R03DA04
ATC
theophylline; systemic, rectal
2.8
8.0
51
196
M79.0
ICD-10 Finland
Rheumatism, unspecified
6.8
8.0
19
29
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.3
7.9
13
10
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.9
7.9
21
37
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.2
7.9
29
73
N03AF01
ATC
carbamazepine; oral, rectal
3.3
7.9
39
126
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.1
7.9
44
152
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.0
7.7
44
156
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
7.7
69
319
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
12.1
7.6
13
11
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
25.4
7.6
10
*
180
Kela drug reimbursment
Interferon alfa
25.4
7.6
10
*
A03FA02
ATC
cisapride; oral, rectal
2.7
7.6
51
200
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
9.1
7.6
15
17
C03DA01
ATC
spironolactone; oral
2.3
7.5
68
316
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.5
7.3
56
237
N06AA10
ATC
nortriptyline; systemic
9.6
7.3
14
15
SPAT1111
SPAT
Planning of analgesia
9.6
7.3
14
15
A02BA03
ATC
famotidine; systemic
3.4
7.3
34
106
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
7.2
53
222
H02AB04
ATC
methylprednisolone; systemic
2.3
7.2
70
335
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
20.4
7.2
10
5
R03AC18
ATC
indacaterol; inhalant
20.4
7.2
10
5
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
5.4
7.1
20
38
N06AA04
ATC
clomipramine; systemic
9.0
7.1
14
16
N02BE51
ATC
paracetamol, combinations excl. psycholeptics; systemic
9.0
7.1
14
16
SPAT1263
SPAT
Sampling
1.7
7.1
180
1231
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
7.1
7.0
16
23
M03BX01
ATC
baclofen; systemic
7.1
7.0
16
23
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
7.0
58
258
P01AB01
ATC
metronidazole; oral, rectal
1.8
7.0
154
1009
H02AB07
ATC
prednisone; oral
2.2
7.0
71
347
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.6
6.9
49
201
284
Kela drug reimbursment
Nintedanib and pirfenidone
14.0
6.9
11
8
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
4.3
6.9
24
58
TGC00
NOMESCO Finland
Bronchial lavation
5.2
6.9
20
40
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
8.4
6.9
14
17
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
11.1
6.8
12
11
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
6.2
6.8
17
28
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
40.6
6.8
8
*
L04AX05
ATC
pirfenidone; oral
17.0
6.8
10
6
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
22.9
6.7
9
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
6.6
6.7
16
25
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.7
6.7
21
46
D70.82
ICD-10 Finland
Drug-induced neutropenia
8.0
6.6
14
18
J01MA01
ATC
ofloxacin; systemic
2.5
6.6
52
225
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
5.2
6.6
19
38
L86
ICPC
Back syndrome with radiating pain
4.6
6.5
21
47
R03BA01
ATC
beclometasone; inhalant
2.2
6.5
66
322
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
5.8
6.5
17
30
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
6.5
37
132
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
7.5
6.4
14
19
SPAT1240
SPAT
Therapeutic discussion
2.9
6.4
37
133
L03AA04
ATC
NA
70.7
6.4
7
*
WX892
NOMESCO Finland
Monitored bed care
2.9
6.4
38
140
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.0
6.4
19
39
A98
ICPC
Health maint/preventive medicine
0.6
6.4
293
3482
A02BC03
ATC
lansoprazole; oral
1.8
6.4
126
794
R03BA05
ATC
fluticasone; inhalant
2.1
6.4
76
400
N06AG02
ATC
moclobemide; oral
4.0
6.4
24
63
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.8
6.4
121
752
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.6
6.3
45
186
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
18.3
6.3
9
5
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
+∞
6.3
6
*
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
+∞
6.3
6
*
GAC10
NOMESCO Finland
Removal of foreign body from pleural cavity
+∞
6.3
6
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
27.0
6.2
8
*
L01CB01
ATC
etoposide; systemic
27.0
6.2
8
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
27.0
6.2
8
*
E0000UV
ATC
NA
1.7
6.2
157
1067
A02BA04
ATC
nizatidine; systemic
2.4
6.2
50
221
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
7.8
6.2
13
17
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.1
6.1
31
104
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.8
6.1
24
66
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
10.2
6.1
11
11
J01MA02
ATC
ciprofloxacin; systemic
1.6
6.1
181
1285
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.7
6.0
16
29
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.1
6.0
31
105

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012501) Base excess in Blood by calculation
112
90
14.91
117.68
10.1
5.0
mmol/l
3.2
2.6
1.01
101
65
(3022806) Fractional oxyhemoglobin in Capillary blood
87
47
21.31
111.88
2.7
2.1
%
87.5
89.2
0.95
87
47
(40767503) Oxygen content in Capillary blood by calculation
102
90
13.33
100.84
3.8
2.3
%
15.6
16.2
0.41
40
52
(1616796) Gas panel - Central venous blood
99
95
12.17
92.52
8.2
4.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
83
68
13.90
85.52
2.4
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
63
52
13.35
64.26
2.1
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
52
31
18.19
63.23
2.1
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
81
99
9.24
62.97
1.6
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
70
71
10.96
62.44
2.2
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
41
17
25.72
58.00
1.9
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
76
95
8.96
57.93
2.2
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
55
44
13.60
57.04
2.3
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
41
18
24.29
56.75
1.9
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
133
317
5.05
53.67
4.2
4.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
56
51
11.95
53.54
2.3
2.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
75
102
8.21
53.26
2.2
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
295
1255
3.54
52.77
7.5
3.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
58
57
11.10
52.71
1.4
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
55
53
11.27
50.62
1.9
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
24
18.20
50.10
1.9
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
50
11.48
49.45
1.9
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
57
60
10.34
49.32
3.3
2.8
e9/l
5.0
4.9
0.09
57
60
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
57
60
10.34
49.32
3.6
3.1
%
63.1
62.9
0.04
57
60
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
163
485
4.18
49.26
8.1
3.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
58
64
9.88
48.48
1.8
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
193
654
3.81
48.40
5.0
2.9
mmol/l
0.8
0.8
2.06
182
615
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
55
57
10.47
48.10
1.9
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
138
370
4.49
47.80
4.4
3.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
96
192
5.72
47.00
1.6
1.8
ug/l
1.1
1.9
0.53
79
172
(3020891) Body temperature
89
172
5.86
45.14
4.4
4.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
205
757
3.53
44.69
2.9
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
31
17
19.13
38.87
3.3
2.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
76
149
5.66
37.78
2.4
3.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
194
784
3.13
35.41
6.0
4.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
345
1915
2.77
34.52
13.4
10.1
inr
1.3
1.3
0.69
172
539
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
95
243
4.43
34.43
1.7
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
100
284
4.00
31.39
7.7
3.7
mmol/l
4.2
2.0
5.20
85
212
(3009343) pH of Capillary blood
101
301
3.80
29.54
7.7
3.7
ph
7.4
7.4
0.29
37
36
(42870588) Differential panel, method unspecified - Blood
265
1384
2.58
28.59
6.7
4.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
101
308
3.71
28.52
7.7
3.6
kpa
5.8
5.2
4.82
96
285
(3021901) Oxygen saturation in Capillary blood
53
98
5.81
27.89
4.5
2.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
366
2239
2.51
27.88
11.7
5.1
umol/l
9.6
12.3
6.19
354
2120
(3036481) Cortisol [Moles/volume] in Serum or Plasma
100
316
3.57
26.70
4.2
1.6
nmol/l
307.6
395.5
3.56
94
286
(3018418) pH of Serum or Plasma
251
1333
2.47
25.50
7.2
3.5
ph
7.4
7.4
0.10
137
235
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
135
532
2.96
24.90
2.7
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
26
24
11.26
24.36
1.5
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
170
783
2.60
23.05
2.1
1.6
mg/l
1.1
1.4
0.93
140
616
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
303
1816
2.29
22.64
7.8
3.7
ng/l
39.4
64.6
0.67
269
1382
(4035726)
100
356
3.15
21.87
1.6
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
129
530
2.80
21.82
2.6
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
186
915
2.46
21.78
2.9
2.7
mosm/kgh2o
505.4
568.5
4.43
170
765
(3003396) Base excess in Arterial blood by calculation
126
517
2.80
21.33
7.5
5.6
mmol/l
2.4
1.3
2.58
110
397
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
44
91
5.12
20.43
1.4
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
48
108
4.73
20.20
1.9
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
324
2063
2.17
20.10
9.0
4.9
mmol/l
1.2
1.2
4.02
305
1815
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
26
32
8.43
19.76
1.7
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
259
1531
2.17
19.21
4.6
3.0
ng/l
1737.4
1871.3
0.18
233
1326
(3006504) Eosinophils/100 leukocytes in Blood
303
1904
2.14
19.18
7.0
4.8
%
2.4
2.9
2.88
293
1748
(3019069) Monocytes/100 leukocytes in Blood
302
1910
2.11
18.63
7.2
5.0
%
8.8
9.0
0.37
293
1759
(3001604) Monocytes [#/volume] in Blood
311
1989
2.11
18.63
7.0
4.7
e9/l
0.7
0.6
2.56
298
1669
(3013650) Neutrophils [#/volume] in Blood by Automated count
351
2352
2.11
18.53
18.2
7.3
e9/l
4.9
4.3
4.74
338
2017
(3006315) Basophils [#/volume] in Blood
312
2001
2.11
18.51
7.0
4.7
e9/l
0.0
0.0
0.40
298
1685
(3013115) Eosinophils [#/volume] in Blood
320
2072
2.10
18.51
7.2
4.8
e9/l
0.2
0.2
1.29
302
1772
(3022096) Basophils/100 leukocytes in Blood
295
1854
2.11
18.46
7.1
4.8
%
0.6
0.7
2.07
287
1703
(3000850) Epithelial cells [#/volume] in Urine
187
982
2.29
18.45
3.1
2.4
e6/l
6.9
4.1
1.26
174
858
(3019198) Lymphocytes [#/volume] in Blood
315
2040
2.09
18.08
7.2
4.8
e9/l
1.7
1.9
1.55
303
1744
(3002030) Lymphocytes/100 leukocytes in Blood
304
1943
2.09
18.08
7.3
5.0
%
21.9
26.5
10.35
295
1783
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
114
486
2.64
17.71
4.1
3.8
ug/l
18.6
12.8
0.33
101
411
(3003434) Protein [Mass/volume] in Pleural fluid
36
71
5.32
17.61
1.6
1.4
g/l
36.7
27.0
3.99
36
64
(3042936) Bacteria identified in Isolate by Culture
122
542
2.55
17.40
2.4
1.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
378
2647
2.07
17.21
8.6
4.0
mmol/l
6.9
6.9
0.05
371
2469
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
81
293
3.02
17.09
1.6
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
237
3498
0.48
16.90
47.2
18.2
g/l
328.4
332.2
6.35
230
3466
(3018010) Neutrophils/100 leukocytes in Blood
296
1916
2.03
16.57
6.7
4.9
%
62.4
58.1
6.49
286
1766
(3024561) Albumin [Mass/volume] in Serum or Plasma
299
1943
2.02
16.55
6.2
4.1
g/l
31.8
35.0
20.25
284
1789
(3015377) Calcium [Moles/volume] in Serum or Plasma
242
1478
2.03
15.74
4.1
3.0
mmol/l
2.3
2.4
2.63
215
1250
(3017181) Myelocytes/100 leukocytes in Blood
84
327
2.81
15.48
2.9
3.8
%
1.3
0.8
1.00
46
93
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
331
2271
1.96
15.27
9.4
5.6
mmol/l
1.2
1.2
4.06
206
1878
(3017569) Oxygen content in Arterial blood
19
22
8.87
15.08
2.6
2.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
77
290
2.89
15.08
2.7
3.5
%
0.6
0.6
0.06
37
59
(3029937) Albumin [Presence] in Urine by Test strip
201
1169
2.06
14.79
5.2
3.8
estimate
0.0
0.0
0.00
115
368
(3030467) Casts [#/volume] in Urine by Automated count
210
1246
2.03
14.59
3.6
3.0
e6/l
0.6
0.5
0.31
186
942
(3025159) Blasts/100 leukocytes in Blood
75
285
2.85
14.43
3.0
3.9
%
0.0
1.5
0.58
40
67
(36304419) Bacteria [Presence] in Urine
200
1181
2.02
13.98
3.7
3.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
347
4420
0.52
13.97
4.1
5.2
mmol/l
2.5
2.6
1.96
276
3961
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
216
1318
1.97
13.70
4.2
2.1
u/l
51.5
61.0
3.02
200
1205
(3041096) Erythrocytes [Presence] in Urine by Automated
194
1141
2.01
13.67
4.2
3.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
45
131
3.62
13.43
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
78
315
2.68
13.35
3.0
3.9
%
0.2
0.1
0.49
42
86
(3002582) Erythrocytes [#/volume] in Urine
222
1393
1.92
12.80
3.8
3.2
e6/l
56.7
99.5
0.98
195
1085
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
11
12.05
12.67
1.2
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
339
4305
0.54
12.66
3.8
4.6
mmol/l
4.4
4.5
1.58
266
3884
(3022948) Iron [Moles/volume] in Serum or Plasma
133
699
2.14
12.57
2.5
2.3
umol/l
10.8
12.9
3.35
123
641
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
250
1640
1.87
12.50
3.7
3.1
—
—
—
0
0
(3004451) EKG impression Narrative
17
22
7.91
12.34
1.8
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
29
66
4.56
12.02
1.4
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
117
604
2.15
11.51
2.6
2.3
%
20.0
23.3
2.01
103
518
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
340
4265
0.56
11.30
3.8
4.6
mmol/l
1.4
1.5
1.74
265
3816
(3013512) EKG study
226
1474
1.83
11.25
5.5
4.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
121
640
2.10
11.16
2.6
2.3
g/l
2.3
2.3
0.35
109
595
(3010503) CD19 cells [#/volume] in Blood
14
16
8.93
11.15
1.4
1.6
e9/l
0.2
0.1
0.58
14
16
(3007853) Bacteria identified in Skin by Aerobe culture
93
450
2.25
10.70
2.2
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
237
1592
1.78
10.55
4.2
3.6
e6/l
137.6
94.9
0.28
198
1155
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
51
1169
0.39
10.14
1.6
1.6
mmol/l
1.6
1.3
1.35
46
936
(3020630) Protein [Mass/volume] in Serum or Plasma
82
387
2.29
9.99
1.9
2.3
g/l
65.4
66.3
0.43
76
356
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
240
1642
1.74
9.88
4.9
3.9
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
14
7
20.41
9.84
1.4
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
56
224
2.65
9.74
9.2
3.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
83
402
2.23
9.50
2.2
1.9
g/l
0.2
0.2
0.30
78
373
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
338
4173
0.59
9.43
6.1
6.2
mmol/mol
41.6
40.7
1.02
280
3778
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
357
4335
0.59
9.14
5.0
4.9
mmol/l
6.0
6.1
0.24
296
3860
(40768806) Pleura Pathology biopsy report
25
63
4.09
9.13
1.6
1.5
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
14
9
15.87
9.06
1.4
1.4
%
11.3
4.9
—
14
9
(21494814) CD8 cells/100 lymphocytes in Specimen
14
9
15.87
9.06
1.3
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
179
1152
1.77
8.97
2.2
2.0
mg/l
3.5
3.1
1.31
150
950
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
335
4122
0.60
8.89
3.6
4.1
mmol/l
1.4
1.2
2.45
258
3662
(3031040) Bacteria [#/volume] in Urine by Automated count
370
2900
1.67
8.82
6.5
4.3
e6/l
3301.1
3337.3
0.00
11
63
(3019309) Folate [Moles/volume] in Red Blood Cells
160
1004
1.80
8.70
2.5
1.7
nmol/l
1423.1
1158.4
2.85
117
726
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
25
6.12
8.68
1.4
1.9
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
26
74
3.62
8.05
1.1
1.2
mmol/l
61.9
57.2
0.23
18
55
(3012441) Differential panel - Pleural fluid
23
60
3.94
8.03
1.5
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
279
2076
1.62
7.87
4.9
3.6
estimate
0.0
0.0
0.00
131
378
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
19
44
4.42
7.73
2.3
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
40
4.60
7.69
2.3
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
277
2079
1.59
7.41
5.9
4.8
estimate
0.0
0.0
0.00
130
380
(3026008) Bacteria identified in Urine by Culture
201
1400
1.64
7.29
3.9
3.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
45
187
2.51
7.27
3.2
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
279
2106
1.58
7.23
5.0
3.6
estimate
0.0
0.0
0.50
126
371
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
137
863
1.75
7.23
5.3
2.7
mmol/l
2.5
2.5
6.87
127
750
(3035637) Corticotropin [Mass/volume] in Plasma
15
30
5.10
7.21
2.2
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
39
4.45
7.00
2.2
2.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
101
590
1.85
6.83
5.7
4.8
mmol/l
1.1
1.0
1.05
93
532
(3011412) CD3 cells [#/volume] in Blood
15
32
4.78
6.72
1.4
1.8
e9/l
0.9
1.0
0.16
15
18
(3009445) Proteinase 3 Ab [Units/volume] in Serum
42
176
2.49
6.68
1.1
1.5
—
15.9
—
0
5
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
40
164
2.54
6.65
4.2
3.1
u/ml
117.7
934.2
0.48
33
140
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
38
152
2.60
6.64
2.6
2.5
u/ml
0.4
0.4
0.10
23
89
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
41
171
2.49
6.59
3.0
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
65
3.47
6.47
1.4
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
41
173
2.47
6.43
1.5
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
19
53
3.67
6.08
1.7
1.4
e6/l
314313.3
34683.2
0.45
12
33
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
403
3379
1.53
6.06
16.0
6.2
u/l
85.1
77.6
3.00
389
3107
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
23
5.30
6.03
1.2
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
27
4.90
5.99
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
158
1082
1.61
5.97
1.8
1.7
pmol/l
76859986.4
6574824.3
0.44
121
867
(3021589) Normoblasts [#/volume] in Blood
249
1895
1.52
5.89
28.6
8.5
e9/l
0.0
0.0
0.81
232
1540
(3023383) Lactate [Moles/volume] in Pleural fluid
10
17
5.96
5.64
1.0
1.2
mmol/l
4.1
3.3
—
10
12
(3000570) Elastase.pancreatic [Mass/mass] in Stool
27
100
2.78
5.50
1.3
1.3
ug/g
253.6
329.5
1.18
17
53
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
177
1270
1.55
5.42
6.0
2.9
u/l
30.6
36.6
1.38
164
1208
(3000494) Fungus identified in Specimen by Culture
78
452
1.83
5.39
2.0
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
23
79
2.98
5.35
4.3
2.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
20
64
3.19
5.23
1.7
1.5
pg
30.9
32.5
0.95
20
64
(3037522) Nuclear Ab [Titer] in Serum
73
419
1.84
5.21
1.2
1.3
titre
396.5
587.0
0.83
23
89
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
114
1664
0.62
5.19
4.1
4.5
%
20.2
22.1
0.80
50
884
(3004809) Band form neutrophils/100 leukocytes in Blood
19
60
3.23
5.08
2.0
4.0
%
1.8
1.2
0.27
14
45
(44790048)
16
45
3.62
5.07
2.5
1.6
—
—
—
0
0
(44806118)
16
45
3.62
5.07
2.5
1.6
—
—
—
0
0
(44790047)
16
45
3.62
5.07
2.5
1.6
—
—
—
0
0
(44790049)
16
45
3.62
5.07
2.5
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
23
4.85
5.03
1.2
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
41
3.72
4.95
1.9
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
41
3.72
4.95
1.9
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
41
3.72
4.95
1.9
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
32
4.13
4.92
1.1
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
358
3007
1.44
4.79
5.7
4.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
7
5
14.13
4.58
1.6
1.0
umol/l
36.9
71.4
—
7
5
(3027945) Reticulocytes/100 erythrocytes in Blood
90
570
1.68
4.57
1.8
2.3
%
2.1
1.7
1.93
74
500
(3000991) Gas panel - Venous blood
60
340
1.85
4.47
10.4
6.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
434
4813
0.69
4.44
53.3
20.0
e9/l
7.6
6.8
10.48
425
4613
(3000963) Hemoglobin [Mass/volume] in Blood
434
4813
0.69
4.44
53.8
20.1
g/l
126.4
134.7
22.22
426
4691
(3017143) Hepatitis C virus Ab [Presence] in Serum
56
311
1.88
4.44
1.3
1.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
434
4812
0.69
4.42
52.9
20.0
e12/l
4.2
4.5
14.05
425
4612
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
176
1310
1.48
4.41
2.9
2.1
u/l
131.2
283.1
1.79
157
1222
(3035941) MCH [Entitic mass]
434
4811
0.69
4.41
52.7
19.9
pg
30.3
30.5
1.31
426
4693
(3024731) MCV [Entitic volume]
434
4811
0.69
4.41
52.7
19.9
fl
92.5
91.6
3.26
426
4693
(3007461) Platelets [#/volume] in Blood
434
4810
0.69
4.39
52.9
20.0
e9/l
255.8
237.0
5.95
425
4631
(3023520) Reticulocytes [#/volume] in Blood
69
412
1.76
4.33
2.2
2.2
e9/l
83.4
64.2
2.67
51
329
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
229
0.25
4.14
1.2
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
77
1175
0.61
4.10
3.1
3.2
ug/l
0.7
0.9
2.07
50
822
(3011544) Albumin [Mass/volume] in Pleural fluid
7
7
10.09
4.02
1.3
1.0
g/l
21.7
18.0
—
7
7
(3021879) Hepatitis B virus core Ab [Presence] in Serum
39
198
2.03
4.01
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
82
2.61
3.92
2.1
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
82
2.61
3.92
2.1
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
11
7.35
3.87
1.4
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
72
452
1.67
3.79
3.7
2.4
umol/l
14.2
8.4
0.80
59
404
(3016750) Collection duration of Urine
12
34
3.58
3.78
2.2
2.1
min
546.6
483.5
—
5
24
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
50
286
1.81
3.64
2.6
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
210
1666
1.39
3.60
3.0
2.5
ug/l
172.9
154.7
0.51
191
1499
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
57
343
1.73
3.51
1.3
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
247
2022
1.36
3.46
3.0
2.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
421
4630
0.73
3.39
20.1
9.5
u/l
23.5
25.1
0.82
404
4389
(4062490)
11
32
3.48
3.34
1.5
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
349
3933
0.75
3.20
6.1
4.4
mu/l
2.1
2.4
0.43
299
3474
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
8
7.56
3.06
1.2
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
21
4.33
3.00
1.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
14
51
2.78
3.00
1.4
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
82
563
1.52
3.00
1.2
1.2
iu/ml
31.0
41.5
0.41
24
169
(3026389) Candida sp identified in Specimen by Organism specific culture
12
40
3.04
2.98
1.3
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
5
10.06
2.98
2.0
3.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
69
2.50
2.98
1.1
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
79
0.00
2.96
0.0
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
17
4.75
2.92
1.1
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
18
4.49
2.80
1.3
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
18
4.49
2.80
1.3
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
29
153
1.94
2.75
5.1
2.6
g/l
0.3
0.3
0.01
19
53
(3052851) Hemolysis interference index of Serum or Plasma
23
112
2.09
2.70
4.6
3.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
113
1477
0.71
2.69
2.9
3.2
mg/l
667.1
361.4
0.21
72
939
(3028707) Methadone [Presence] in Urine by Screen method
8
20
4.04
2.57
27.9
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
44
2.76
2.56
1.3
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
44
2.76
2.56
1.3
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
373
4112
0.77
2.55
37.2
13.2
ml/min/173m2
75.3
73.5
0.85
335
3346
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
45
2.70
2.46
1.3
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
45
2.70
2.46
1.3
1.1
u/ml
1.5
1.7
—
6
16
(3004775) Volume in Urine collected for unspecified duration
12
45
2.70
2.46
2.1
2.3
ml
782.0
593.9
—
5
30
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
45
2.70
2.46
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
45
2.70
2.46
1.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
77
2.24
2.39
1.2
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
46
2.64
2.37
1.3
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
61
416
1.52
2.33
4.0
3.2
mmol/l
2.7
2.1
0.70
52
325
(3023103) Potassium [Moles/volume] in Serum or Plasma
431
4644
0.77
2.31
42.0
16.5
mmol/l
4.0
4.0
1.25
422
4483
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
13
4.65
2.27
1.8
2.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
18
3.92
2.25
1.7
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
18
3.92
2.25
1.7
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
18
3.92
2.25
1.7
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
36
218
1.69
2.24
5.4
3.6
%
46.6
46.5
0.01
36
213
(46235355) HIV 1 and 2 tests - Meaningful Use set
58
395
1.52
2.24
1.6
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
29
3.13
2.23
4.0
2.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
24
3.36
2.18
2.9
2.7
—
—
—
0
0
(3000012) Reticulocyte production index
8
24
3.36
2.18
1.5
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
158
1284
1.31
2.18
2.8
2.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
431
4630
0.78
2.14
41.9
16.4
mmol/l
138.6
139.8
14.09
422
4468
(40761511) CBC panel - Blood by Automated count
417
4497
0.79
2.14
38.2
13.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
126
1566
0.76
2.10
4.1
3.9
mg/mmol
13.9
7.9
0.74
77
994
(40768441) Liver Pathology biopsy report
8
25
3.23
2.10
1.0
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
120
1501
0.75
2.10
4.6
3.0
mmol/l
7.2
7.4
0.16
89
1235
(40768797) Stomach Pathology biopsy report
76
554
1.42
2.09
1.4
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
22
117
1.91
2.08
4.3
3.1
nmol/l
0.9
0.9
0.01
17
97
(3023183) Ammonium ion [Moles/volume] in Plasma
18
89
2.05
2.07
2.6
2.2
umol/l
32.0
36.4
0.42
13
74
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
76
2.13
2.04
1.5
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
44
2.53
2.02
6.8
3.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
26
3.10
2.02
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
173
2052
0.78
2.00
4.8
5.2
ug/l
2.4
3.0
0.49
134
1802
(3000492) Spirometry study
46
306
1.54
1.99
2.4
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
123
978
1.32
1.98
16.0
5.6
—
—
—
0
0
(4010399)
42
274
1.57
1.98
1.8
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
408
0.57
1.97
1.2
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
11
4.57
1.94
1.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
158
0.37
1.91
1.3
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
134
1085
1.30
1.89
2.7
2.6
umol/l
17289.6
12144.2
0.15
106
916
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
12
4.19
1.82
1.0
1.1
%
34.4
27.8
—
5
5
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
35
2.59
1.80
24.8
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
232
1.59
1.80
15.8
7.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
41
2.46
1.76
1.1
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
220
1906
1.24
1.76
5.4
3.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
47
324
1.49
1.75
2.1
1.7
%
1.9
1.6
1.05
37
263
(3013707) Erythrocyte sedimentation rate by Westergren method
349
3173
1.22
1.74
5.3
3.7
mm/h
21.9
13.4
10.52
318
2837
(3051651) Icteric interference index of Serum or Plasma
7
24
2.94
1.72
2.6
2.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
46
0.00
1.71
0.0
3.8
—
39.2
—
0
39
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
11
48
2.31
1.71
1.3
1.1
u/ml
3.8
3.0
—
5
21
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
19
104
1.85
1.69
1.5
2.3
g/l
3.7
3.6
0.03
19
97
(4015189)
5
14
3.59
1.62
3.4
2.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
14
3.59
1.62
1.0
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.7
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.7
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.7
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.7
1.4
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
6
21
2.87
1.51
2.0
1.1
u/l
4.8
8.4
—
6
14
(3016879) Cocaine [Presence] in Urine
10
45
2.24
1.47
22.8
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
44
313
1.44
1.43
1.7
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
70
540
1.33
1.42
1.2
1.2
u/ml
20.9
15.5
0.10
15
194
(40768800) Prostate Pathology biopsy report
6
136
0.44
1.41
1.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
46
2.19
1.40
22.9
1.3
—
—
—
0
0
(4306422)
9
41
2.21
1.37
1.2
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
6
23
2.62
1.37
1.7
1.3
nmol/l
0.1
0.2
—
6
14
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
54
2.06
1.33
2.4
2.7
—
737.4
—
0
5
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
32
217
1.50
1.33
3.5
2.2
%
1.7
1.1
1.52
32
217
(3024354) Oxygen [Partial pressure] in Venous blood
47
345
1.39
1.31
4.1
2.6
kpa
4.0
4.3
0.71
47
332
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
43
2.11
1.30
1.9
4.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
48
2.10
1.28
23.5
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
48
2.10
1.28
22.6
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
35
2.30
1.27
1.0
1.1
u/ml
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
11
56
1.98
1.22
3.3
3.1
—
20.7
—
0
13
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
19
2.64
1.22
1.0
3.2
u/l
232.2
204.8
—
5
19
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
71
1.85
1.20
1.2
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
109
1.67
1.20
1.6
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
12
64
1.89
1.18
1.9
1.4
nmol/l
46.9
45.2
0.08
12
59
(3017732) Neutrophils [#/volume] in Blood
34
241
1.43
1.16
2.4
2.8
e9/l
5.0
4.1
0.90
24
165
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
57
441
1.32
1.16
3.5
2.3
ug/l
4.6
6.8
0.65
51
389
(3000093) Morphology [Interpretation] in Blood Narrative
8
39
2.06
1.15
1.4
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
20
2.51
1.15
2.2
2.6
—
620.6
—
0
9
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
65
1.86
1.14
1.6
1.4
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
40
2.01
1.12
2.3
3.4
nmol/l
7.5
5.7
—
8
40
(3011288) Drugs identified in Urine by Screen method
7
31
2.27
1.10
3.7
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
105
1.64
1.07
2.5
2.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
605
0.76
1.04
3.3
4.6
%
40.3
32.8
1.93
25
361
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
22
2.28
1.03
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
44
334
1.34
1.03
4.4
3.0
ml/min/173m2
55.8
59.0
0.23
22
143
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
49
1.85
0.99
1.2
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
355
3764
0.87
0.97
28.0
14.9
%
36.5
38.8
2.14
143
2369
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
69
1.75
0.97
1.2
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
0
31
0.00
0.96
0.0
1.7
—
—
—
0
0
(4281824)
7
37
1.90
0.94
1.4
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
28
2.15
0.91
2.0
5.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
63
1.76
0.90
1.1
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
30
2.01
0.87
2.5
2.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
77
649
1.21
0.82
27.4
26.5
inr
1.3
1.4
—
7
92
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
43
339
1.29
0.81
3.6
2.0
u/l
34.5
38.1
0.25
37
286
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
223
0.66
0.80
1.2
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
10
58
1.74
0.80
1.1
1.2
—
14.7
—
0
5
(3020961) Endomysium IgA Ab [Titer] in Serum
9
147
0.61
0.80
1.0
1.1
—
10.2
—
0
5
(3027944) Amphetamines [Presence] in Urine
8
48
1.68
0.79
30.9
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
44
351
1.27
0.77
2.0
2.1
ug/g
225.2
149.0
0.47
34
273
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
34
1.77
0.76
1.5
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
78
665
1.20
0.75
1.4
1.3
g/l
2.9
2.6
0.52
51
395
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
107
0.56
0.73
1.2
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
25
2.01
0.73
1.0
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
25
332
0.74
0.72
3.2
3.5
ng/l
102.9
89.9
0.13
15
288
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
432
0.77
0.72
1.4
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
10
60
1.68
0.72
5.9
2.8
u/ml
48.5
21.2
—
10
60
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
40
1.76
0.71
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
29
375
0.76
0.70
1.4
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
93
1.52
0.70
1.1
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
180
1647
1.13
0.69
2.2
2.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
269
2521
1.12
0.69
4.4
2.8
u/l
80.0
49.5
1.37
239
2290
(3051611) Lipemic interference index of Serum or Plasma
7
43
1.63
0.67
3.0
3.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
70
599
1.19
0.66
18.8
6.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
13
87
1.50
0.63
1.1
1.1
—
4.3
—
0
9
(4211845)
0
22
0.00
0.59
0.0
2.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
72
1.54
0.59
1.8
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(4268621)
6
35
1.72
0.58
1.8
2.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
83
937
0.87
0.56
6.3
3.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
20
262
0.76
0.56
1.3
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
10
65
1.55
0.55
1.5
1.5
pmol/l
148.5
145.2
—
10
65
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
20
151
1.34
0.54
2.9
2.3
mg/l
28.7
41.1
0.98
15
122
(3034860) Kappa light chains.free [Mass/volume] in Serum
20
151
1.34
0.54
2.9
2.3
mg/l
136.9
90.2
0.30
15
121
(3044941) Cell count panel - Synovial fluid
9
60
1.51
0.54
1.9
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
45
379
1.20
0.52
4.4
3.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
75
1.47
0.51
4.5
2.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
46
1.53
0.48
1.3
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
11
76
1.46
0.48
4.5
2.0
mmol/l
106.0
105.3
0.21
11
76
(3041354) Potassium [Moles/volume] in Venous blood
11
76
1.46
0.48
4.5
2.0
mmol/l
4.2
4.1
0.09
11
76
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
12
86
1.40
0.44
1.1
1.1
—
3.3
—
0
6
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
92
0.65
0.42
1.2
2.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
32
1.57
0.42
5.6
17.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
95
0.63
0.42
1.2
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
15
0.00
0.41
0.0
1.1
—
353.0
—
0
8
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
6.4
—
0
6
(3019225) pH of Specimen
52
456
1.15
0.40
4.2
3.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.1
—
39.9
—
0
7
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
11
149
0.73
0.40
1.2
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
60
1.34
0.40
1.4
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
18
0.00
0.40
0.0
3.0
—
—
—
0
0
(1002224) Polysomnography panel
7
102
0.68
0.40
1.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
106
1.33
0.39
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
106
1.33
0.39
1.4
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(4024509)
5
36
1.39
0.38
2.0
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
68
1.33
0.37
1.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
113
0.70
0.37
1.5
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
107
1.32
0.37
1.4
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
87
950
0.90
0.37
6.4
3.9
kg/l
1.0
1.0
0.99
14
152
(3044889) 12 lead EKG panel
308
3187
0.93
0.36
6.8
4.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
42
1.43
0.35
2.0
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
2.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
44
1.37
0.34
1.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
18
145
1.25
0.34
1.3
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
20
240
0.83
0.31
2.3
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
104
971
1.09
0.30
2.8
2.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
94
1.28
0.28
2.0
2.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
340
3485
0.95
0.26
41.6
16.9
%
14.7
13.7
19.71
333
3387
(3019230) Fractional oxyhemoglobin in Venous blood
5
74
0.67
0.26
1.8
1.9
%
37.3
61.3
—
5
74
(40768443) Skin Pathology biopsy report
17
202
0.84
0.25
1.1
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
85
0.70
0.24
1.5
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
94
0.74
0.22
1.0
1.1
—
14.4
—
0
6
(3003327) Ova and parasites identified in Stool by Light microscopy
13
107
1.22
0.21
1.8
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
29
258
1.13
0.21
3.0
3.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
12
0.00
0.21
0.0
7.6
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
0.6
—
0
6
(3036670) Protein [Mass/volume] in Synovial fluid
0
13
0.00
0.21
0.0
1.2
—
30.0
—
0
5
(4034850)
11
134
0.82
0.21
32.8
10.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
191
1975
0.95
0.20
2.1
2.0
pmol/l
93.8
94.2
0.05
110
1003
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
125
1195
1.06
0.20
1.5
1.5
nmol/l
20.6
20.4
0.06
105
997
(3003694) ABO and Rh group [Type] in Blood
106
1113
0.94
0.20
1.8
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
50
1.20
0.19
1.0
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
79
745
1.07
0.19
3.5
2.7
e6/l
0.9
1.1
0.35
52
445
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
81
1.24
0.19
1.0
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
24
213
1.13
0.18
4.7
4.3
%
2.3
1.6
0.68
24
202
(3005570) Glucose [Moles/volume] in Urine
7
58
1.21
0.18
2.0
1.7
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
13
110
1.19
0.17
1.7
2.1
mg/l
7.3
12.2
1.78
13
102
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
94
898
1.05
0.16
5.3
3.8
ng/l
169.8
353.9
0.63
77
773
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
130
0.84
0.16
1.5
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
160
0.87
0.14
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
17
191
0.89
0.14
1.0
1.2
iu/ml
139.2
122.6
—
5
68
(4094501)
8
98
0.81
0.13
1.0
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
75
716
1.05
0.13
3.5
3.0
e6/l
2.4
1.8
0.20
49
422
(3049717) Cytology report of Urine Cyto stain
25
228
1.10
0.13
2.9
2.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
148
0.88
0.12
1.4
1.6
—
—
—
0
0
(3039000) Anion gap in Blood
10
115
0.87
0.10
6.1
5.6
mmol/l
10.0
11.8
—
10
106
(3018572) Chloride [Moles/volume] in Blood
10
115
0.87
0.10
6.1
5.6
mmol/l
104.9
105.0
—
10
106
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
47
1.06
0.09
1.2
1.1
g/l
1.6
1.5
—
5
41
(1761868) Lipid panel - Serum or Plasma
133
1360
0.97
0.09
3.0
3.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
46
440
1.05
0.08
1.2
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
23
215
1.07
0.07
1.3
1.3
—
70.9
—
0
7
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
77
1.04
0.07
1.9
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
132
0.91
0.06
1.4
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
183
0.93
0.06
2.4
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
105
1028
1.03
0.06
6.6
3.5
%
90.6
85.5
1.08
99
1001
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
119
1.09
0.06
4.5
2.4
ug/min
62.5
90.3
—
6
69
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
151
0.93
0.05
1.4
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
159
1.07
0.05
3.9
3.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
33
318
1.04
0.04
3.2
3.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
29
301
0.96
0.04
2.9
2.8
e6/l
0.2
0.3
0.46
29
296
(3002256) Pathology report gross observation
57
579
0.98
0.02
1.2
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
13
123
1.06
0.01
2.8
1.3
g/l
0.0
0.0
0.00
13
115
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
126
0.95
0.00
1.1
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
176
0.96
0.00
1.9
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
13
135
0.96
0.00
2.8
1.4
g/l
0.0
0.0
0.00
13
124
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
13
126
1.03
0.00
2.8
1.3
g/l
0.0
0.0
0.00
13
116
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
25
248
1.01
0.00
2.4
2.4
—
13.9
—
0
5
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
74
737
1.00
0.00
1.3
1.2
u/ml
0.7
1.4
2.00
22
178
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
172
1723
1.00
0.00
2.5
2.1
nmol/l
76.8
79.4
0.54
145
1502
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
431
4307
1.00
0.00
41.8
13.3
mg/l
25.8
27.0
0.43
410
3352
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
317
3173
1.00
0.00
5.3
3.5
pmol/l
15.5
15.0
1.86
280
2782
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
8
0.00
0.00
0.0
8.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.1
—
99.1
—
0
7
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
70
1.00
0.00
1.1
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
5.8
—
6.6
—
0
5
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
74.6
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
97
0.93
0.00
1.1
1.5
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
1.6
—
0
6
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_MORPHIN – Morphin

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).